Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
NANO-X IMAGING LTD (Nanox) (NASDAQ: NNOX) is a medical imaging technology company that combines imaging hardware, AI-based software, cloud infrastructure, and teleradiology services. The Nanox news feed on this page aggregates company press releases and market updates so readers can follow how Nanox advances its imaging platform, commercial strategy, and capital markets activity over time.
Nanox’s recent news highlights its Nanox.ARC and Nanox.ARC X multi-source digital tomosynthesis systems, including CE Mark certification for Nanox.ARC in Europe and FDA 510(k) clearance for Nanox.ARC X for general use in multiple clinical indications. Articles also cover distribution agreements and collaborations with partners in countries such as France, the Czech Republic, Greece, Romania, Serbia, Montenegro, and Bosnia and Herzegovina, reflecting efforts to expand clinical and commercial deployment of its imaging solutions.
Another key news theme is the growth of Nanox.AI and its imaging analytics portfolio. Press releases describe AI algorithms that analyze routine CT scans for early signs associated with chronic diseases and bone health solutions such as HealthVCF and HealthOST, which have been included in an Early Value Assessment by the UK National Institute for Health and Care Excellence. Updates also discuss acquisitions like VasoHealthcare IT, intended to support deployment of AI solutions across U.S. healthcare facilities.
Investors and analysts can also find financial results announcements, guidance updates, and details of registered direct offerings and other financings, as reported in Nanox’s press releases and related SEC filings. Together, these news items provide insight into Nanox’s commercialization progress, clinical collaborations, AI development roadmap, and capital strategy. Bookmark this page to access an organized stream of Nanox news, from product and partnership updates to financial and regulatory disclosures.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that its CEO, Ran Poliakine, will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit from September 21-23, 2020. The presentation is scheduled for September 22, 2020, at 9:10 am ET. The event will be webcast live, with access available through both a dedicated link and the company's website. Nanox focuses on developing a cost-effective digital X-ray source for real-world medical applications aimed at improving early detection services.
NANO-X IMAGING LTD (NASDAQ: NNOX) responded to unusual trading activities attributed to a Citron Research report dated September 15, 2020. The Company refutes the report's allegations, labeling them as baseless and misleading. Nanox is investigating the claims and promises to provide further clarity as necessary. Founded by Ran Poliakine, Nanox is focused on developing a cost-effective digital X-ray source aimed at improving medical imaging accessibility.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in two investor conferences. The first event is the Jefferies Asia Forum on September 16, 2020, at 4:00 PM HK time, followed by the Cantor Virtual Global Healthcare Conference on September 15, 2020, at 9:20 AM EDT. Audio for both events will be available via webcast on the company's website, with archives accessible for 90 days. Founded by Ran Poliakine, Nanox develops innovative digital X-ray technology aimed at reducing medical imaging costs and improving accessible healthcare.